TNFSF10 and neoplasm: Although TRAIL-mediated cell death in tumor cells shows significant therapeutic value, some reports have revealed potential toxicity to human hepatocytes, thymocytes, prostate epithelial and neural cells, thus raising safety concerns that these adverse outcomes may be related to TRAIL-mediated damage59, 60, 61, 62, 63, 64.